Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun;43(2):323-356.
doi: 10.1016/j.anclin.2025.01.001. Epub 2025 Feb 15.

Cardiac Surgery-Associated Acute Kidney Injury: An Updated Review of Current Preventive Strategies

Affiliations
Review

Cardiac Surgery-Associated Acute Kidney Injury: An Updated Review of Current Preventive Strategies

Kirolos A Jacob et al. Anesthesiol Clin. 2025 Jun.

Abstract

Acute kidney injury (AKI) is a frequent and often severe postoperative complication following cardiac surgery, which is associated with poor outcomes in both the short and long terms. Numerous randomized clinical trials have been conducted to investigate various strategies for prevention of cardiac surgery-associated AKI. Unfortunately, most trials conducted to date have been negative. However, encouraging results have been reported with several interventions, including preoperative implementation of oxygen delivery-directed perfusion, novel drugs such as teprasiran and amino acids. Many of these studies, however, require validation in larger, multicenter trials, before their routine use in clinical practice can be recommended.

Keywords: Acute kidney injury; Cardiac surgery; Perioperative care; Prevention; Randomized clinical trial.

PubMed Disclaimer

Conflict of interest statement

Disclosure D.E. Leaf received research support from BioPorto, Denmark, BTG International Ltd, United Kingdom, Metro International Biotech LLC, Renibus Therapeutics, Inc, and Alexion Pharmaceuticals, has served as a consultant for Sidereal Therapeutics, Casma Therapeutics, MexBrain, Entrada Therapeutics, CardioRenal Systems, Inc, and Alexion Pharmaceuticals, and served as a Co-Chair of a Safety Monitoring Committee for EMD Serono Research and Development Institute, Inc. The authors have nothing to disclose.

MeSH terms

LinkOut - more resources